Citation
Pormohammad, Ali, et al. "Comparison of Confirmed COVID-19 With SARS and MERS Cases - Clinical Characteristics, Laboratory Findings, Radiographic Signs and Outcomes: a Systematic Review and Meta-analysis." Reviews in Medical Virology, vol. 30, no. 4, 2020, pp. e2112.
Pormohammad A, Ghorbani S, Khatami A, et al. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev Med Virol. 2020;30(4):e2112.
Pormohammad, A., Ghorbani, S., Khatami, A., Farzi, R., Baradaran, B., Turner, D. L., Turner, R. J., Bahr, N. C., & Idrovo, J. P. (2020). Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Reviews in Medical Virology, 30(4), e2112. https://doi.org/10.1002/rmv.2112
Pormohammad A, et al. Comparison of Confirmed COVID-19 With SARS and MERS Cases - Clinical Characteristics, Laboratory Findings, Radiographic Signs and Outcomes: a Systematic Review and Meta-analysis. Rev Med Virol. 2020;30(4):e2112. PubMed PMID: 32502331.
TY - JOUR
T1 - Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis.
AU - Pormohammad,Ali,
AU - Ghorbani,Saied,
AU - Khatami,Alireza,
AU - Farzi,Rana,
AU - Baradaran,Behzad,
AU - Turner,Diana L,
AU - Turner,Raymond J,
AU - Bahr,Nathan C,
AU - Idrovo,Juan-Pablo,
Y1 - 2020/06/05/
PY - 2020/04/08/received
PY - 2020/04/21/revised
PY - 2020/04/22/accepted
PY - 2020/6/6/pubmed
PY - 2020/7/21/medline
PY - 2020/6/6/entrez
KW - COVID-19
KW - Middle East respiratory syndrome coronavirus
KW - SARS virus
KW - coronavirus
KW - meta-analysis
KW - severe acute respiratory syndrome
SP - e2112
EP - e2112
JF - Reviews in medical virology
JO - Rev Med Virol
VL - 30
IS - 4
N2 - INTRODUCTION: Within this large-scale study, we compared clinical symptoms, laboratory findings, radiographic signs, and outcomes of COVID-19, SARS, and MERS to find unique features. METHOD: We searched all relevant literature published up to February 28, 2020. Depending on the heterogeneity test, we used either random or fixed-effect models to analyze the appropriateness of the pooled results. Study has been registered in the PROSPERO database (ID 176106). RESULT: Overall 114 articles included in this study; 52 251 COVID-19 confirmed patients (20 studies), 10 037 SARS (51 studies), and 8139 MERS patients (43 studies) were included. The most common symptom was fever; COVID-19 (85.6%, P < .001), SARS (96%, P < .001), and MERS (74%, P < .001), respectively. Analysis showed that 84% of Covid-19 patients, 86% of SARS patients, and 74.7% of MERS patients had an abnormal chest X-ray. The mortality rate in COVID-19 (5.6%, P < .001) was lower than SARS (13%, P < .001) and MERS (35%, P < .001) between all confirmed patients. CONCLUSIONS: At the time of submission, the mortality rate in COVID-19 confirmed cases is lower than in SARS- and MERS-infected patients. Clinical outcomes and findings would be biased by reporting only confirmed cases, and this should be considered when interpreting the data.
SN - 1099-1654
UR - https://www.unboundmedicine.com/medline/citation/32502331/Comparison_of_confirmed_COVID_19_with_SARS_and_MERS_cases___Clinical_characteristics_laboratory_findings_radiographic_signs_and_outcomes:_A_systematic_review_and_meta_analysis_
DB - PRIME
DP - Unbound Medicine
ER -